Intelligent Bio Solutions Inc.
INBS
$4.00
-$0.02-0.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.29M | -10.87M | -10.57M | -10.26M | -10.70M |
| Total Depreciation and Amortization | 1.19M | 1.21M | 1.21M | 1.20M | 1.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 769.80K | 734.60K | 398.60K | 211.50K | 386.60K |
| Change in Net Operating Assets | -43.50K | -1.22M | -720.90K | -1.56M | -1.02M |
| Cash from Operations | -9.38M | -10.14M | -9.68M | -10.41M | -10.10M |
| Capital Expenditure | -361.50K | -302.20K | -231.80K | -190.60K | -173.60K |
| Sale of Property, Plant, and Equipment | 40.20K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -321.40K | -302.20K | -231.80K | -190.60K | -173.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.14M | 8.09M | 4.58M | 3.98M | 13.89M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -3.04M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 20.60K | 20.60K | 20.60K | 20.60K | 592.40K |
| Cash from Financing | 8.16M | 8.11M | 4.60M | 4.00M | 11.45M |
| Foreign Exchange rate Adjustments | 42.90K | -3.60K | 27.20K | 10.50K | -49.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.50M | -2.33M | -5.28M | -6.59M | 1.12M |